Kevin Erickson

Polycystic kidney disease specialist

Instructor, Medicine - Nephrology

Kidney Clinic (Nephrology)

  • 300 Pasteur Drive
  • Stanford, CA 94305
  • Phone: 650-723-6961
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

MS, Stanford University, Health Services Research (2012)

Fellowship: Stanford University Division of Nephrology (2011) CA

Residency: Emory University School of Medicine (2009) GA

Internship: Emory University School of Medicine (2007) GA

Medical Education: University of Pennsylvania (2006) PA

Board Certification: Nephrology, American Board of Internal Medicine (2011)

Board Certification: Internal Medicine, American Board of Internal Medicine (2010)

Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients.
Shen, J. I., Montez-Rath, M. E., Mitani, A. A., Erickson, K. F., & Winkelmayer, W. C. (2014). Correlates and variance decomposition analysis of heparin dosing for maintenance hemodialysis in older US patients. Pharmacoepidemiology and drug safety, 23(5), 515-525.

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of internal medicine, 159(6), 382-389.

Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease
Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. ANNALS OF INTERNAL MEDICINE, 159(6), 382-?.

Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.
Erickson, K. F., Tan, K. B., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2013). Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clinical journal of the American Society of Nephrology , 8(6), 987-994.

Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease.
Erickson, K. F., Japa, S., Owens, D. K., Chertow, G. M., Garber, A. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Journal of the American College of Cardiology, 61(12), 1250-1258.

Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.
Erickson, K. F., Lea, J., & McClellan, W. M. (2013). Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clinical journal of the American Society of Nephrology , 8(1), 75-81.

The Challenges of Cost-Effectiveness Analyses for the Clinician
Erickson, K. F., & Winkelmayer, W. C. (2010). The Challenges of Cost-Effectiveness Analyses for the Clinician. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(6), 1023-1025.